Not medical advice. Talk to your provider before using any peptide. Full disclaimer
HCG (Human Chorionic Gonadotropin)
Beginner tier: 250 IU, EOD · community consensus
Also known as: HCG, hCG, Pregnyl
Just 250 IU every other day kept intratesticular testosterone at 93% of baseline in the Coviello 2005 trial (n=29)[1]. HCG is a glycoprotein hormone that mimics luteinizing hormone, and it's become the standard tool for preserving testicular function on TRT. The FDA approved it decades ago under brand names Pregnyl, Novarel, and Ovidrel. One complication: compounding pharmacies lost the right to produce HCG in March 2020 after BPCIA reclassification, pushing costs from $20 to $289 or more per vial. Men on testosterone replacement still reach for it because nothing else matches the evidence for preventing atrophy and protecting fertility.
What Is HCG (Human Chorionic Gonadotropin)?
HCG (human chorionic gonadotropin, CAS 9002-61-3) is a 36.7 kDa glycoprotein produced naturally during pregnancy that binds the same receptor as LH on Leydig cells. Coviello and colleagues settled the dose question in 2005 [1]: at 250 IU every other day, intratesticular testosterone dropped only 7% from baseline; at 500 IU EOD, it climbed 26% above baseline. Without HCG, intratesticular testosterone fell to near zero. It binds the same receptor as LH on Leydig cells, triggering testosterone synthesis through the cAMP signaling cascade. Think of it as a long-acting LH substitute that bypasses the pituitary entirely.
In practice, HCG sits at the center of two worlds. Fertility clinics use it under FDA-labeled indications for hypogonadotropic hypogonadism. TRT clinics prescribe it off-label to prevent testicular atrophy and maintain sperm production in men on exogenous testosterone. The community protocols at 250 to 500 IU every other day line up precisely with the published dose-response data.
The regulatory situation changed sharply in March 2020. On March 23, 2020, approved HCG applications were deemed biologics licenses under the BPCIA (FDA's deemed-BLA list). Brand-name Pregnyl or Novarel now runs about $289 per 10,000 IU vial at a discounted cash price, up from $20 to $40 when compounded versions were available. That cost shift pushed many US telehealth clinics toward gonadorelin as a compounded substitute, though no direct RCT proves gonadorelin matches HCG for intratesticular testosterone maintenance.
How HCG (Human Chorionic Gonadotropin) Works
HCG binds to the LH/CG receptor (LHCGR) on Leydig cells in the testes. That receptor activation triggers the cAMP second messenger cascade, which drives cholesterol into the steroidogenic pathway and produces testosterone. The same receptor sits on Sertoli cells indirectly supporting spermatogenesis through paracrine signaling.
What makes HCG useful during TRT is its ability to bypass the hypothalamic-pituitary axis completely. Exogenous testosterone shuts down the brain's GnRH pulse generator, which stops LH secretion. Leydig cells lose their signal, shrink, and stop producing testosterone locally. HCG replaces that missing LH signal at the gonadal level.
The glycoprotein's molecular weight (36.7 kDa) gives it a half-life of roughly 33 hours, confirmed by the Pregnyl FDA label and Rizkallah's pharmacokinetic work. Endogenous LH has a half-life of about 20 minutes. That difference is why 250 to 500 IU every other day provides steady Leydig cell stimulation; you don't need continuous infusion or daily dosing. Subcutaneous bioavailability sits around 95%, clinically equivalent to intramuscular injection. Peak levels arrive at approximately 12 to 20 hours after subcutaneous administration.
One limitation: HCG does not directly stimulate FSH receptors. Sertoli cell function depends on both testosterone (provided by HCG-stimulated Leydig cells) and FSH. In severe hypogonadotropic hypogonadism, HCG monotherapy produces sperm in about 78% of men, but adding exogenous FSH pushes outcomes higher (41 studies, n=1,673)[2].
HCG (Human Chorionic Gonadotropin) Benefits
- HCG benefits center on testicular preservation, fertility maintenance, and hormonal support during testosterone replacement therapy.
- Preserves intratesticular testosterone at 93% of baseline on just 250 IU every other day, per the Coviello 2005 dose-response study (n=29)[1].
- Prevents testicular atrophy, the most consistently reported benefit across more than 2,000 threads on r/trt and r/Testosterone.
- Maintains sperm production during TRT. Hsieh 2013 [3] tracked 26 men on concurrent TRT and 500 IU HCG every other day; zero developed azoospermia, and 9 achieved pregnancy.
- FDA-approved with decades of clinical data supporting its safety profile, unlike most peptides on the market.
- Real-world 2025 cohort data [4] confirmed 84 to 89% of anabolic steroid users showed sperm count improvement on similar HCG protocols, with median counts climbing from 18 million to 147 million.
- Supports the full hormone cascade as an LH mimetic, maintaining downstream metabolites like estradiol that contribute to mood and sexual function.
HCG (Human Chorionic Gonadotropin): Science vs Community Consensus
Strong evidence that HCG maintains intratesticular testosterone (ITT) during exogenous testosterone use and preserves spermatogenesis.
Read the evidence (key study, limitations)
Dose-response established: 250 IU EOD maintains ITT at ~93% of baseline; 500 IU EOD brings ITT ~26% above baseline. HCG + FSH combination superior to HCG monotherapy for restoring spermatogenesis in severe hypogonadotropic hypogonadism. FDA-approved for fertility indications with decades of clinical data.
Coviello et al. 2005 (PMID 15713727): ITT dose-response in men on 200 mg/week testosterone enanthate; n=29. Confirmed: 250 IU EOD = -7% ITT vs baseline; 500 IU EOD = +26% ITT above baseline.
Most TRT-adjunct ITT data from small trials. No large RCT comparing HCG to gonadorelin for ITT maintenance in TRT patients. Long-term Leydig desensitization threshold (>1,500 IU/injection) based on animal data and clinical inference, not prospective human RCT.
Widely regarded as the gold standard for testicular preservation and fertility maintenance on TRT.
Read the reports (what users report 4, common issues 5)
Community protocols closely mirror clinical data. Cost and availability since the March 2020 BPCIA transition are the dominant barriers; gonadorelin has largely replaced compounded HCG at US telehealth clinics.
- Prevents testicular atrophy: most consistently reported benefit across r/trt threads
- Preserves fertility and sperm production during TRT
- Maintains libido and sexual sensitivity during testosterone suppression
- Some users report subjective wellbeing benefit attributed to intratesticular testosterone production
- Elevated estradiol requiring AI management: most common complaint
- Cost since the March 2020 BPCIA transition: Pregnyl/Novarel $289-$465/vial vs $20-40 for former compounded HCG
- Acne and oily skin at doses above 500 IU
- EOD injection frequency burdensome for some users
- Some men remain azoospermic despite HCG: not universally effective for fertility
Community protocols at 250-500 IU EOD precisely match the Coviello 2005 dose-response data. PCT protocols align with 2026 clinical cohort data (PMID 41147237). No significant divergence between science and community on dosing or indication.
HCG (Human Chorionic Gonadotropin) Dosage Guide
Reconstitution math for a 5,000 IU vial with 2 mL bacteriostatic water: you get 2,500 IU per mL, or 250 IU per 10 units on a standard 100-unit insulin syringe. For 500 IU, draw to the 20-unit mark. For 1,500 IU (PCT dosing), that's 60 units.
Always use bacteriostatic water, not sterile water. Multi-dose vials need the benzyl alcohol preservative. Sterile water accelerates degradation fast after reconstitution.
Store reconstituted HCG refrigerated at 2 to 8 degrees Celsius and use within 60 days per the Pregnyl label. Lyophilized powder keeps at room temperature for up to 60 days or refrigerated for up to 2 years.
The thing most beginners miss: since March 23, 2020, FDA says HCG is not eligible for the 503A/503B compounding exemptions. If a telehealth clinic offers "compounded HCG," that product falls outside both exemptions. The discounted cash price for Pregnyl 10,000 IU runs roughly $289 at retail pharmacies. Check the NDC number on your vial to confirm it matches the Organon or Ferring product.
Cycling
Typically used continuously alongside TRT, not cycled. For PCT, 2-4 weeks is common. Doses above 1,500 IU per injection risk Leydig cell desensitization.
For TRT adjunct use, HCG is administered continuously at doses ≤500 IU EOD to avoid Leydig cell LHCGR downregulation. Doses >1,500 IU per injection risk chronic receptor desensitization, reducing responsiveness over time. PCT use is inherently time-limited (2-4 months): the protocol self-terminates when spermatogenesis is restored. No formal "cycling on/off" schedule is indicated for continuous low-dose TRT adjunct use.
- Declining testicular volume despite continued HCG use at stable dose (possible receptor downregulation)
- Loss of prior E2 elevation on same dose (reduced steroidogenic Leydig cell response)
- Worsening libido or mood symptoms not explained by TRT dose changes
Or use the universal Peptide Calculator for any peptide.
HCG (Human Chorionic Gonadotropin) Protocols by Goal
Expected: Testicular volume maintained or improved. ITT preserved at ~93% of baseline vs near-zero suppression without HCG. Minimal E2 elevation at 250 IU for most men: AI often not required.
Monitor: Check estradiol (E2) at 4-6 weeks after starting. Many men do not need an AI at 250 IU EOD. No semen analysis required unless fertility is a goal.
How to Use HCG (Human Chorionic Gonadotropin)
- 1Step 1
Gather your supplies: HCG vial (5,000 IU or 10,000 IU), bacteriostatic water, a mixing syringe, and a 29 to 31 gauge insulin syringe (0.5 mL or 1 mL).
- 2Reconstitute the vial
For a 5,000 IU vial, inject 2 mL of bacteriostatic water slowly down the side of the vial. Swirl gently until dissolved. Do not shake.
- 3Draw your dose using a 100-unit insulin syringe
At 2,500 IU per mL concentration: 10 units on the syringe equals 250 IU; 20 units equals 500 IU; 60 units equals 1,500 IU.
- 4Clean the injection site with an alcohol swab
Subcutaneous injection into abdominal fat is preferred by most TRT clinics. Pinch a fold of skin, insert the needle at a 45 to 90 degree angle, inject slowly, release the pinch.
- 5Step 5
Rotate injection sites across the abdomen, alternating sides. Thigh and upper arm are acceptable alternatives.
- 6Cap the vial, return it to the refrigerator immediately
Date the vial on reconstitution day. Discard after 60 days.
- 7Typical frequency is every other day for TRT adjunct use
Space injections evenly across the week (Monday, Wednesday, Friday works for 3x/week PCT protocols).
Alternative Routes
No dose adjustment: SC bioavailability ~95%, clinically equivalent to IM
More comfortable; easier to self-administer; less post-injection soreness. Abdominal fat, thigh, or upper arm acceptable sites. Tmax slightly delayed vs IM (~12 hours SC vs ~6 hours IM per Pregnyl label), not clinically relevant for EOD or 3x/week TRT dosing. Use 29-31G insulin syringe, 4-8mm needle.
Same dose as SC; no adjustment needed
FDA label specifies IM for all labeled indications. Tmax ~6 hours IM per Pregnyl label. More painful than SC. Deltoid or gluteal sites. More common in clinical fertility protocols; SC broadly substituted in TRT practice.
HCG (Human Chorionic Gonadotropin) Stacking Protocols
Works With
HCG has not been eligible for the 503A/503B compounding exemptions since March 2020 (FDA). Gonadorelin has largely replaced compounded HCG at US TRT clinics as a compounded LH-stimulating alternative. Acts at pituitary level (vs HCG at gonadal level); stimulates both LH and FSH. Some clinics run both: brand-name HCG for proven ITT maintenance + gonadorelin to maintain pituitary axis stimulation.
Gonadorelin 100-200 mcg SC 2x/day (compounded) or pulsatile 50-100 mcg every 90 min (pump). Typically used as HCG substitute, not simultaneous addition.
Upstream HPG axis stimulator. Not a practical HCG alternative while on TRT: exogenous testosterone suppresses kisspeptin signaling at hypothalamic level, blunting efficacy. Potentially useful during post-TRT HPG axis recovery phase. Very limited human male data as of 2025; FDA PCAC nominated for TRT spermatogenesis indication (Oct 2024) but not yet approved for compounding.
Avoid
Continuous GnRH agonist use causes LH/FSH suppression via pituitary receptor downregulation, directly opposing HCG's LH-mimetic effect on Leydig cells. Combination is physiologically counterproductive.
Do not combineBlocks pituitary GnRH receptors, suppressing endogenous LH/FSH. While HCG bypasses the pituitary, combining with GnRH antagonists creates unpredictable hormonal disruption without clear therapeutic rationale outside closely supervised fertility protocols.
Estimated Cost
Pricing updated 2026-04-09
HCG (Human Chorionic Gonadotropin) Side Effects
Raised estradiol is the primary management challenge with HCG. The mechanism is straightforward: HCG stimulates Leydig cells to produce testosterone, and aromatase converts a portion of that testosterone to estradiol. Men with higher body fat or genetic aromatase polymorphisms are more susceptible. At 250 IU every other day, most men manage without an aromatase inhibitor. At 500 IU and above, symptomatic estradiol elevation becomes common enough that labs at 4 to 6 weeks are standard practice.
Water retention and bloating follow from estradiol elevation and tend to appear at moderate to high doses. Gynecomastia risk exists if estrogen climbs unchecked, particularly in men already prone to breast tissue sensitivity. Nipple tenderness or puffiness warrants bloodwork, not panic.
Leydig cell desensitization is the risk that gets less attention but matters most over time. Chronic dosing above 1,500 IU per injection can downregulate LHCGR expression on Leydig cells, reducing their responsiveness to both HCG and endogenous LH. This threshold comes from animal data and clinical inference rather than a prospective human RCT, but it's the reason every experienced protocol caps individual injections at 1,500 IU. Signs include declining testicular volume despite continued use and loss of the estradiol elevation you'd expect at a given dose.
Injection site reactions are typical for both intramuscular and subcutaneous administration. Pain, redness, and mild swelling at the injection site affect a subset of users. Rotating sites and using 29 to 31 gauge insulin needles minimizes discomfort.
Acne and oily skin show up in community reports at doses above 500 IU, consistent with the higher intratesticular testosterone production at those levels.
Headache and irritability appear in clinical literature and user reports without a clear dose-response pattern.
Not everyone responds to HCG for fertility. Some men remain azoospermic despite adequate dosing; HCG targets Leydig cells but doesn't directly stimulate Sertoli cells. FSH addition is the standard next step for non-responders [2].
When to stop or seek medical evaluation: persistent gynecomastia symptoms, hematocrit above 52%, signs of Leydig desensitization (declining response at stable dose), or any allergic reaction. Contraindicated in hormone-sensitive cancers (prostate, breast), precocious puberty, and pregnancy unless under direct fertility specialist supervision.
Common Issues & Solutions
Estradiol rising after HCG: HCG drives Leydig cell testosterone production, which aromatizes to E2. Test E2 at 4-6 weeks; add anastrozole 0.25-0.5 mg or exemestane 12.5 mg on injection days only if confirmed elevated and symptomatic. Do not add AI preemptively without labs.
Testicular volume not recovering after 3 months: Increase from 250 IU to 500 IU EOD. For active fertility, 500 IU EOD is the minimum evidence-backed dose (Hsieh 2013). If still insufficient at 6 months, add FSH (Gonal-F or Follistim): HCG drives testosterone but FSH is required for full Sertoli cell support and spermatogenesis.
Azoospermia persisting despite HCG: HCG targets Leydig cells (testosterone) but not Sertoli cells directly. FSH is required for full spermatogenesis. Add FSH stimulation per specialist; PMID 39445789 meta-analysis confirms HCG + FSH combination superior to HCG alone for sperm output in hypogonadotropic hypogonadism.
Cost and supply since March 23, 2020: HCG is not eligible for the 503A/503B compounding exemptions (FDA). Brand-name Pregnyl/Novarel ~$289 discounted cash price. Consider gonadorelin (compounded, ~$30-50/month) as a cost-accessible alternative: note no direct RCT proving ITT equivalence to HCG for TRT adjunct.
Using sterile water instead of bacteriostatic water: Multi-dose vials require bacteriostatic water (0.9% benzyl alcohol preservative). Sterile water has no preservative and significantly accelerates degradation after reconstitution. Always use bac water for HCG vials.
Ask AI about this page
Ask AI for a second opinion on HCG (Human Chorionic Gonadotropin) dosing and side effects
Contraindications
- Pregnancy (unless under direct fertility specialist supervision)
- Hormone-sensitive cancers (prostate, breast)
- Precocious puberty
- Known hypersensitivity to HCG
- Androgen-dependent neoplasm
Drug Interactions
- Aromatase inhibitors (commonly co-prescribed to manage estradiol)
- Exogenous testosterone (standard combination in TRT fertility protocols)
- SERMs like clomiphene (sometimes stacked in PCT)
- GnRH agonists/antagonists (opposing mechanisms: avoid combining)
- Continuous GnRH agonist use causes LH/FSH suppression via pituitary receptor downregulation, directly opposing HCG's LH-mimetic effect on Leydig cells. Combination is physiologically counterproductive.
Product Quality
Since the BPCIA transition on March 23, 2020, FDA says HCG is not eligible for the 503A/503B compounding exemptions. FDA-licensed products include Pregnyl (Organon), Novarel (Ferring) and Ovidrel (EMD Serono). Grey-market risk is low for domestic brand-name products. Risk exists for any "compounded HCG" offered by US telehealth platforms: it falls outside both exemptions and may be mislabeled or counterfeit.
- Use only licensed US pharmacies dispensing Pregnyl or Novarel: verify the NDC matches the brand product
- Do not accept "compounded HCG" from US telehealth platforms or pharmacies: since March 23, 2020, it is outside the 503A/503B compounding exemptions (FDA)
- Pregnyl 10,000 IU: ~$430 retail list vs. ~$289 discounted cash price at retail pharmacies
- Cold chain is critical: Pregnyl must be refrigerated after reconstitution (2-8°C); inspect packaging for signs of temperature excursion
- International pharmacy sourcing (Canada, Mexico): quality and cold-chain compliance are unverified
Recommended Monitoring
| Test | When | Target |
|---|---|---|
| Estradiol (E2): sensitive LC-MS/MS assay preferred | Baseline before starting HCG; repeat at 4-6 weeks; every 3 months ongoing | Symptomatic threshold varies by individual; many men tolerate up to 40-50 pg/mL; treat based on symptoms + labs, not labs alone |
| Total and free testosterone | Routine TRT monitoring schedule; baseline before HCG addition | Not listed |
| Semen analysis | Baseline (if fertility is goal); at 3 months and 6 months on HCG | WHO 2021 reference: >16M/mL concentration, >42% motility, >4% normal morphology (Kruger strict) |
| LH and FSH | Baseline; primarily useful post-TRT during PCT to track HPG axis recovery. Not useful during active TRT (will be suppressed). | Not listed |
| Hematocrit / CBC | Every 6 months on TRT + HCG | Hematocrit <52% (men) |
HCG stimulates Leydig cell testosterone production, which aromatizes to E2 via aromatase. E2 elevation is the most common management issue on HCG.
HCG may elevate total T above TRT target at higher doses: informs TRT dose adjustments.
Only objective measure of spermatogenesis response. Identifies non-responders requiring FSH addition.
Post-TRT, LH and FSH recovery confirms HPG axis normalization. Useful to time SERM tapering in PCT.
HCG-stimulated intratesticular testosterone production may contribute to erythrocytosis on top of TRT-driven erythropoiesis.
HCG (Human Chorionic Gonadotropin) Before and After
LH receptor activation begins. Intratesticular testosterone rises. Some men notice improved testicular fullness.
Testicular volume stabilizes or increases. Sperm parameters begin improving.
Full effect on intratesticular testosterone. Semen analysis may show improvement.
Spermatogenesis typically restored. Fertility potential significantly improved vs TRT-only.
What to Expect
Week 1 to 2: LH receptor activation and early ITT rise. HCG binds LHCGR on Leydig cells within hours. Intratesticular testosterone starts climbing within days. Many users report subjective testicular fullness in the first week; some notice improved mood or libido that could be ITT-driven or placebo. Mild injection site reactions are common. Estradiol elevation begins, check labs at week 4.
Week 3 to 4: Testicular volume increases and sperm production begins responding to restored ITT levels. Atrophy visibly reverses for most men. Estradiol-related symptoms (water retention, nipple sensitivity) may appear in men with higher aromatase activity. Anastrozole or exemestane gets added based on lab confirmation at this stage.
Week 6 to 8: ITT plateau reached for your dosing tier. Early semen analysis improvement is possible. Testicular size is subjectively "back to normal" for most users on community forums. Libido and sexual sensitivity hold steady. AI dosing typically stabilizes by this window. Acne may appear at higher doses (500 to 1,000 IU).
Month 3 to 6: Spermatogenesis confirmed in the majority of men on 500 IU every other day. Hsieh 2013 [3] recorded 9 out of 26 pregnancies by month 6 on HCG plus TRT. Real-world 2025 cohort data [4] showed median sperm counts jumping from 18 million to 147 million, with an 84% improvement rate and 6 pregnancies during the study period. Non-responders with persistent azoospermia typically add FSH at this point.
PCT Month 3 to 12: HPG axis normalization after anabolic steroid use. A 2026 cohort (n=79)[5] confirmed 87.5% normozoospermia at 12 months with HCG 1,500 IU 3x/week plus clomiphene, compared to 69.2% with clomiphene alone and 58.6% with no treatment. Testicular volume increased 20% or more in 70.8% of combined-therapy patients. Recovery runs slower after longer or heavier AAS cycles. Men who used concurrent HCG during their cycle recover faster in PCT.
Detailed Timeline: Science vs Community
HCG binds LHCGR on Leydig cells within hours of injection. ITT begins rising within days. cAMP cascade initiated; steroidogenesis increases.
Subjective testicular fullness reported within first week by many users. Some report improved mood or libido: possibly ITT-driven, possibly placebo.
Testicular volume measurably increases. Spermatogenesis begins responding to restored ITT levels. Scrotal fullness returns.
Testicular fullness consistently reported. Atrophy visibly reversing. E2-related symptoms (water retention, nipple sensitivity) may appear in men with higher aromatase activity.
ITT plateau reached per dosing tier. Early semen analysis improvement possible. Hsieh 2013 data: significant sperm parameter improvement measurable by month 3.
Testicular size subjectively "back to normal" for most. Libido and sexual sensitivity maintained. AI dosing typically stabilizes by week 6-8.
Spermatogenesis restored in majority on 500 IU EOD. Hsieh 2013 (PMID 23260550): 9/26 pregnancies by month 6 on HCG + TRT. Real-world 2025 cohort (PMID 40620361): median sperm count 18M → 147M; 84% improvement rate; 6 pregnancies during study.
Fertility success frequently reported at 3-6 month mark. Non-responders (azoospermia persisting) noted: prompts FSH addition discussion.
PMID 41147237 (2026): 87.5% normozoospermia at 12 months with HCG + SERM. PMID 38399562 (2024): ~96% spermatogenesis restoration within 12 months post-TRT with combined protocol. Testicular volume ≥20% increase in 70.8% of combined-therapy patients.
Recovery slower after longer or heavier AAS cycles. Men who ran concurrent HCG during cycle recover significantly faster in PCT. HCG blast before SERM-only PCT is common community practice.
Pharmacokinetics
Source: Pregnyl FDA label; confirmed by Rizkallah et al.
Pharmacokinetics: Active Dose Over Time
t½ = ~33 hoursDisclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only, not medical advice.
Molecular Profile
Is HCG (Human Chorionic Gonadotropin) Legal?
HCG is FDA-approved under brand names Pregnyl (Organon), Novarel (Ferring), and Ovidrel (EMD Serono) for fertility indications including hypogonadotropic hypogonadism and ovulation induction. HCG is a prescription-only drug, and its use alongside TRT is off-label.
The critical regulatory change happened on March 23, 2020. Under the Biologics Price Competition and Innovation Act (BPCIA), approved HCG applications became biologics licenses that day (FDA's deemed-BLA list). FDA's notice to compounders names human chorionic gonadotropin among the affected substances. It says these transitioning biological products are not eligible for the 503A and 503B compounding exemptions. Product sold in the US as "compounded HCG" since then falls outside both exemptions and may be mislabeled or counterfeit.
FDA-licensed HCG (Pregnyl, Novarel, Ovidrel and a Fresenius Kabi chorionic gonadotropin) is dispensed by prescription. Imported HCG (Canada, Mexico) raises cold-chain and quality verification concerns.
HCG is banned by the World Anti-Doping Agency (WADA) at all times for male athletes under the S2 category (peptide hormones, growth factors, and related substances). A positive test results in a sanction.
This content is for educational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before using any prescription medication.
Who Should Consider HCG (Human Chorionic Gonadotropin)
- Men on TRT wanting to preserve fertility
- Men experiencing testicular atrophy from testosterone use
- Couples undergoing fertility treatment
- Men in post-cycle therapy (PCT)
Related Peptides
What Changed for HCG (Human Chorionic Gonadotropin)
Peptide Schedule Research TeamReviewed Apr 7, 202610 Citations
References
- [1]Low-dose HCG maintains intratesticular testosterone in men with testosterone-induced gonadotropin suppression (opens in a new tab)(n=29)PubMed (opens in a new tab)PubMed
- [2]Efficacy of gonadotropin treatment for induction of spermatogenesis in men with pathologic gonadotropin deficiency: a meta-analysis (Muir et al., Clin Endocrinol 2025) (opens in a new tab)(n=1,673)PubMed (opens in a new tab)PubMed
- [3]Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy (J Urol 2013) (opens in a new tab)PubMed (opens in a new tab)PubMed
- [4]Efficacy of human chorionic gonadotropin hormone in restoring spermatogenesis in men using non-prescribed androgens: a retrospective analysis of real-world data (F S Rep 2025) (opens in a new tab)PubMed (opens in a new tab)PubMed
- [5]Post-cycle therapy after short-term anabolic-androgenic steroid use (BJU Int 2026) (opens in a new tab)(n=79)PubMed (opens in a new tab)PubMed
Additional References
- Pregnyl (chorionic gonadotropin) FDA Label (opens in a new tab)FDA Label
- Indications for HCG use in management of infertility in hypogonadal men (opens in a new tab)Review
- Management of Male Fertility in Hypogonadal Patients on Testosterone Replacement Therapy (Medicina (Kaunas) 2024) (opens in a new tab)PubMed 38399562PubMed
- FDA: Notice to compounders, changes that affect compounding as of March 23, 2020 (content current as of March 5, 2020) (opens in a new tab)Review
- FDA: List of approved NDAs for biological products that were deemed to be BLAs on March 23, 2020 (opens in a new tab)Review
Related Tools
Storage & Stability
Frequently Asked Questions
How popular is HCG (Human Chorionic Gonadotropin)?
Hot. A popularity tier (hot, popular, emerging or niche), based on search volume and community activity.
Reddit: 2,000+. Community mentions on Reddit: ~2,000+ threads across r/trt, r/steroids, r/Testosterone. Open r/trt (opens in a new tab).
4,636 papers on PubMed, the US library of medical research. Search them on PubMed (opens in a new tab).
Very high search interest. A band for how often people search Google for the name each month.
These come from this site's peptide records. They are not live counts.